Clinical Trial Update: Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy [Phase 3]

View source ↗

Summary

GlaxoSmithKline-sponsored Phase 3 trial evaluating ofatumumab for rheumatoid arthritis in patients with inadequate response to TNF-α antagonists was terminated;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Arzerra (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: TERMINATED | Results posted: 2011-11-28